Drug Resistance and the Role of Combination Chemotherapy in Improving Patient Outcomes
Resistance to cancer chemotherapy is a common phenomenon especially in metastatic breast cancer (MBC), a setting in which patients typically have had exposure to multiple lines of prior therapy. The subsequent development of drug resistance can result in rapid disease progression during or shortly a...
Saved in:
| Main Author: | Denise A. Yardley |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | International Journal of Breast Cancer |
| Online Access: | http://dx.doi.org/10.1155/2013/137414 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
by: A. M. Tikhonov, et al.
Published: (2018-03-01) -
Amiodarone and Ravuconazole Combination Potentiates Chemotherapy against Drug-Resistant Trypanosoma cruzi Strains
by: Breno Vilas Boas Raimundo, et al.
Published: (2025-05-01) -
Mechanisms of drug resistance to neoadjuvant chemotherapy in breast cancer
by: K. A. Aliev, et al.
Published: (2024-10-01) -
ECONOMIC FEASIBILITY OF NEW CHEMOTHERAPY REGIMENS FOR TREATMENT OF TUBERCULOSIS PATIENTS WITH EXTENSIVE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2018-07-01) -
Preventive chemotherapy in children exposed to multiple drug resistant tuberculosis
by: V. A. Аksenova, et al.
Published: (2019-07-01)